Kinase inhibition in rheumatoid arthritis: a big advance?
- PMID: 23294499
- DOI: 10.1016/S0140-6736(12)61722-X
Kinase inhibition in rheumatoid arthritis: a big advance?
Comment on
-
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial.Lancet. 2013 Feb 9;381(9865):451-60. doi: 10.1016/S0140-6736(12)61424-X. Epub 2013 Jan 5. Lancet. 2013. PMID: 23294500 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical